Hologic, Inc. (HOLX) Given Buy Rating at BTIG Research
's stock had its "buy" rating reiterated by BTIG Research in a research report issued on Sunday. They currently have a $47.00 price target on the stock.
from Biotech News
's stock had its "buy" rating reiterated by BTIG Research in a research report issued on Sunday. They currently have a $47.00 price target on the stock.
The most important thing is to improve and not stop. Even if you have taken some course, this does not mean that you are now a guru. You need to constantly practice, learn something new.
0 Comments